Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.
3.

Anticandidal activity of Pseudomonas aeruginosa strains isolated from clinical specimens.

Kaleli I, Cevahir N, Demir M, Yildirim U, Sahin R.

Mycoses. 2007 Jan;50(1):74-8.

PMID:
17302753
4.
5.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
7.

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.

Krcmery V, Barnes AJ.

J Hosp Infect. 2002 Apr;50(4):243-60. Review.

PMID:
12014897
8.

[Anti-candidal activity of clinical Pseudomonas aeruginosa strains and in vitro inhibition of Candida biofilm formation].

Keçeli Özcan S, Dündar D, Sönmez Tamer G.

Mikrobiyol Bul. 2012 Jan;46(1):39-46. Turkish.

PMID:
22399170
9.

[Pseudomonas aeruginosa and Candida albicans interaction in the respiratory tract: from pathophysiology to a therapeutic perspective].

Ader F, Faure K, Guery B, Nseir S.

Pathol Biol (Paris). 2008 May;56(3):164-9. Epub 2007 Oct 1. French.

PMID:
17905537
10.

Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90.

Matthews RC, Rigg G, Hodgetts S, Carter T, Chapman C, Gregory C, Illidge C, Burnie J.

Antimicrob Agents Chemother. 2003 Jul;47(7):2208-16.

11.
12.

Growth of fresh human isolates of some Candida species at 45 degrees C.

Bezjak V, Chandy R.

J Med Vet Mycol. 1989;27(3):197-200.

PMID:
2674386
14.

Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study.

Mokaddas EM, Al-Sweih NA, Khan ZU.

J Med Microbiol. 2007 Feb;56(Pt 2):255-9.

PMID:
17244809
15.

Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.

Chavanet P, Lopez J, Grappin M, Bonnin A, Duong M, Waldner A, Buisson M, Camerlynck P, Portier H.

AIDS. 1994 Jul;8(7):945-50.

PMID:
7946104
16.

Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.

Xiao M, Fan X, Chen SC, Wang H, Sun ZY, Liao K, Chen SL, Yan Y, Kang M, Hu ZD, Chu YZ, Hu TS, Ni YX, Zou GL, Kong F, Xu YC.

J Antimicrob Chemother. 2015 Mar;70(3):802-10. doi: 10.1093/jac/dku460. Epub 2014 Dec 3.

PMID:
25473027
17.
18.

Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.

Colombo AL, Nakagawa Z, Valdetaro F, Branchini ML, Kussano EJ, Nucci M.

Med Mycol. 2003 Jun;41(3):235-9.

PMID:
12964715
19.

Oral Candida albicans isolates from HIV-positive individuals have similar in vitro biofilm-forming ability and pathogenicity as invasive Candida isolates.

Junqueira JC, Fuchs BB, Muhammed M, Coleman JJ, Suleiman JM, Vilela SF, Costa AC, Rasteiro VM, Jorge AO, Mylonakis E.

BMC Microbiol. 2011 Nov 4;11:247. doi: 10.1186/1471-2180-11-247.

20.

[Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].

Mujica MT, Finquelievich JL, Jewtuchowicz V, Iovannitti CA.

Rev Argent Microbiol. 2004 Jul-Sep;36(3):107-12. Spanish.

PMID:
15559191

Supplemental Content

Support Center